Corbus Pharmaceuticals Holdings, Inc. (CRBP) Institutional Ownership

Based on Q1 2026 13F filings, institutional ownership of Corbus Pharmaceuticals Holdings, Inc. stands at 112.1%, held across 102 reporting institutions.

Cormorant Asset Management, LP is the largest reported institutional holder of CRBP, with approximately 2,344,971 shares worth $0.02B as of Q1 2026.

Yes — 4 widely-followed marquee investors appear among the top 25 institutional holders of CRBP, including CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC.

Our composite Smart Money Score for CRBP is 72 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

23 institutions opened new positions in CRBP during Q1 2026, while 20 fully exited. 65 added to existing positions and 14 trimmed.

CRBP institutional ownership rose by 7.44 percentage points quarter-over-quarter, with a net change of +3 holders.

The top 10 institutions account for 74.8% of all reported 13F value in CRBP, and the top 25 account for 92.5%.

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.